This inventor holds 2 USPTO granted patents. Top assignees: Ciba Geigy Japan Limited, Japat Limited. Active years: 1997-1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997-1998
Title: The Innovations of Thomas Fruh
Introduction
Thomas Fruh is a notable inventor based in Magden, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of endothelin receptor antagonists. With a total of two patents to his name, Fruh's work has had a meaningful impact on medical research and treatment options.
Latest Patents
Fruh's latest patents focus on antagonists of endothelin receptors. These innovations are crucial in addressing various health conditions related to the endothelin system, showcasing his commitment to advancing medical science.
Career Highlights
Throughout his career, Thomas Fruh has worked with prominent companies such as Ciba Geigy Japan Limited and Japat Limited. His experience in these organizations has allowed him to hone his skills and contribute to groundbreaking research in the pharmaceutical industry.
Collaborations
Fruh has collaborated with esteemed colleagues, including Toshiki Murata and Thomas Pitterna. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the quality of his work.
Conclusion
In summary, Thomas Fruh is a distinguished inventor whose work on endothelin receptor antagonists has made a significant impact in the field of pharmaceuticals. His career reflects a dedication to innovation and collaboration, contributing to advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile